XLerateHealth Awarded $2.5M NIH Phase IIB Grant to Accelerate National Expansion of Its Enterprise Commercialization Engine

LOUISVILLE, Ky.–(BUSINESS WIRE)– #Biotech–XLerateHealth receives $2.5M NIH/NIGMS Phase IIB grant to scale its Commercialization Engine for universities, biotech hubs, health systems and ESOs.